+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Injectable Drug Delivery Market by Device Type, Usability, Therapeutic Application, End-user - Global Forecast 2025-2030- Product Image
Injectable Drug Delivery Market by Device Type, Usability, Therapeutic Application, End-user - Global Forecast 2025-2030- Product Image
Sale

Injectable Drug Delivery Market by Device Type, Usability, Therapeutic Application, End-user - Global Forecast 2025-2030

  • PDF Icon

    Report

  • 188 Pages
  • October 2024
  • Region: Global
  • 360iResearch™
  • ID: 5977713
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Injectable Drug Delivery Market grew from USD 972.25 billion in 2023 to USD 1.04 trillion in 2024. It is expected to continue growing at a CAGR of 7.58%, reaching USD 1.62 trillion by 2030.

The scope of the injectable drug delivery market encompasses a variety of devices and formulations designed to administer drugs directly into the body through needles and syringes. This method is necessary for delivering drugs that are poorly absorbed orally, require rapid onset, or need direct delivery to specific tissues. Applications are broad and include chronic disease management (e.g., diabetes with insulin injections), emergency treatment (e.g., epinephrine for anaphylaxis), and vaccine delivery. End-use sectors involve hospitals, clinics, and home care settings, due to the growing preference for at-home healthcare services. The market's growth is predominantly driven by an increasing prevalence of chronic diseases, technological advancements in delivery systems (like auto-injectors and wearable injectors), and a burgeoning elderly population. Opportunities lie in the development of patient-centric, minimally invasive delivery methods that enhance compliance and safety, such as needle-free injectors and smart connected devices providing real-time data.

However, challenges such as the high cost of advanced technologies, regulatory hurdles, and concerns about needle-stick injuries and waste disposal impede progress. Economic disparities limit access in low-income regions, hindering market expansion. Innovation is encouraged in the design of biodegradable microwearables and integrating AI for dose monitoring to mitigate these issues. There's also potential in biosimilars and biologics, poised for growth in chronic conditions treatment. The market exhibits a competitive but fragmented nature, allowing for niche targeting and personalized healthcare approaches. Research into biologics, device miniaturization, and alternative delivery systems is vital for capturing growth. Healthcare providers should focus on education regarding benefits and safe practices, while manufacturers invest in eco-friendly packaging solutions to reduce environmental impact, which can provide a competitive edge. These strategic moves and technical innovations are projected to pave the way for a more robust injectable drug delivery market presence.

Understanding Market Dynamics in the Injectable Drug Delivery Market

The Injectable Drug Delivery Market is rapidly evolving, shaped by dynamic supply and demand trends. These insights provide companies with actionable intelligence to drive investments, develop strategies, and seize emerging opportunities. A comprehensive understanding of market dynamics also helps organizations mitigate political, geographical, technical, social, and economic risks while offering a clearer view of consumer behavior and its effects on manufacturing costs and purchasing decisions.
  • Market Drivers
    • Technological advancements in needle technology
    • Increasing prevalence of chronic diseases
    • Significant rise in elderly population worldwide
  • Market Restraints
    • High development costs of injectable drug delivery solutions
  • Market Opportunities
    • Development of smart injection devices
    • Increasing demand for self-administration devices
  • Market Challenges
    • Low patient compliance of needles and lack of training in using injectable devices

Exploring Porter’s Five Forces for the Injectable Drug Delivery Market

Porter’s Five Forces framework further strengthens the insights of the Injectable Drug Delivery Market, delivering a clear and effective methodology for understanding the competitive landscape. This tool enables companies to evaluate their current competitive standing and explore strategic repositioning by assessing businesses’ power dynamics and market positioning. It is also instrumental in determining the profitability of new ventures, helping companies leverage their strengths, address weaknesses, and avoid potential pitfalls.

Applying PESTLE Analysis to the Injectable Drug Delivery Market

External macro-environmental factors deeply influence the performance of the Injectable Drug Delivery Market, and the PESTLE analysis provides a comprehensive framework for understanding these influences. By examining Political, Economic, Social, Technological, Legal, and Environmental elements, this analysis offers organizations critical insights into potential opportunities and risks. It also helps businesses anticipate changes in regulations, consumer behavior, and economic trends, enabling them to make informed, forward-looking decisions.

Analyzing Market Share in the Injectable Drug Delivery Market

The Injectable Drug Delivery Market share analysis evaluates vendor performance. This analysis provides a clear view of each vendor’s standing in the competitive landscape by comparing key metrics such as revenue, customer base, and other critical factors. Additionally, it highlights market concentration, fragmentation, and trends in consolidation, empowering vendors to make strategic decisions that enhance their market position.

Evaluating Vendor Success with the FPNV Positioning Matrix in the Injectable Drug Delivery Market

The Injectable Drug Delivery Market FPNV Positioning Matrix is crucial in evaluating vendors based on business strategy and product satisfaction levels. By segmenting vendors into four quadrants - Forefront (F), Pathfinder (P), Niche (N), and Vital (V) - this matrix helps users make well-informed decisions that best align with their unique needs and objectives in the market.

Strategic Recommendations for Success in the Injectable Drug Delivery Market

The Injectable Drug Delivery Market strategic analysis is essential for organizations aiming to strengthen their position in the global market. A comprehensive review of resources, capabilities, and performance helps businesses identify opportunities for improvement and growth. This approach empowers companies to navigate challenges in the increasingly competitive landscape, ensuring they capitalize on new opportunities and align with long-term success.

Key Company Profiles

The report delves into recent significant developments in the Injectable Drug Delivery Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Antares Pharma by Halozyme Therapeutics, Becton, Dickinson and Company, Eli Lilly and Company, Emperra GmbH, Enable Injections LLC, F. Hoffman - La Roche Ltd., Insulet Corporation, Johnson & Johnson Services, Inc., Medtronic PlC, Novo Nordisk A/S, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SiO2 Medical Products, Stevanato Group, Tandem Diabetes Care, West Pharmaceutical Services, Inc., and Wilhelm Haselmeier GmbH & Co. KG.

Market Segmentation & Coverage

This research report categorizes the Injectable Drug Delivery Market to forecast the revenues and analyze trends in each of the following sub-markets:
  • Device Type
    • Conventional Injection Devices
    • Self-injection Devices
      • Autoinjectors
      • Needle-free Injectors
      • Pen Injectors
      • Wearable Injectors
  • Usability
    • Disposable
    • Reusable
  • Therapeutic Application
    • Autoimmune Diseases
    • Cancer
    • Chronic Diseases
    • Hormonal Therapies
    • Infectious Diseases
  • End-user
    • Home Care Settings
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report provides a detailed overview of the market, exploring several key areas:

  1. Market Penetration: A thorough examination of the current market landscape, featuring comprehensive data from leading industry players and analyzing their reach and influence across the market.
  2. Market Development: The report identifies significant growth opportunities in emerging markets and assesses expansion potential within established segments, providing a roadmap for future development.
  3. Market Diversification: In-depth coverage of recent product launches, untapped geographic regions, significant industry developments, and strategic investments reshaping the market landscape.
  4. Competitive Assessment & Intelligence: A detailed analysis of the competitive landscape, covering market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, technological advancements, and innovations in manufacturing by key market players.
  5. Product Development & Innovation: Insight into groundbreaking technologies, R&D efforts, and product innovations that will drive the market in future.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current size of the market, and how is it expected to grow?
  2. Which products, segments, and regions present the most attractive investment opportunities?
  3. What are the prevailing technology trends and regulatory factors influencing the market?
  4. How do top vendors rank regarding market share and competitive positioning?
  5. What revenue sources and strategic opportunities guide vendors' market entry or exit decisions?

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Technological advancements in needle technology
5.1.1.2. Increasing prevalence of chronic diseases
5.1.1.3. Significant rise in elderly population worldwide
5.1.2. Restraints
5.1.2.1. High development costs of injectable drug delivery solutions
5.1.3. Opportunities
5.1.3.1. Development of smart injection devices
5.1.3.2. Increasing demand for self-administration devices
5.1.4. Challenges
5.1.4.1. Low patient compliance of needles and lack of training in using injectable devices
5.2. Market Segmentation Analysis
5.2.1. Device Type: Increasing preference for self-injection devices due to ease of use
5.2.2. End-user: Exploring applications in home care settings due to safety and portability
5.3. Porter’s Five Forces Analysis
5.3.1. Threat of New Entrants
5.3.2. Threat of Substitutes
5.3.3. Bargaining Power of Customers
5.3.4. Bargaining Power of Suppliers
5.3.5. Industry Rivalry
5.4. PESTLE Analysis
5.4.1. Political
5.4.2. Economic
5.4.3. Social
5.4.4. Technological
5.4.5. Legal
5.4.6. Environmental
6. Injectable Drug Delivery Market, by Device Type
6.1. Introduction
6.2. Conventional Injection Devices
6.3. Self-injection Devices
6.3.1. Autoinjectors
6.3.2. Needle-free Injectors
6.3.3. Pen Injectors
6.3.4. Wearable Injectors
7. Injectable Drug Delivery Market, by Usability
7.1. Introduction
7.2. Disposable
7.3. Reusable
8. Injectable Drug Delivery Market, by Therapeutic Application
8.1. Introduction
8.2. Autoimmune Diseases
8.3. Cancer
8.4. Chronic Diseases
8.5. Hormonal Therapies
8.6. Infectious Diseases
9. Injectable Drug Delivery Market, by End-user
9.1. Introduction
9.2. Home Care Settings
9.3. Hospitals & Clinics
10. Americas Injectable Drug Delivery Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Injectable Drug Delivery Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Injectable Drug Delivery Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. Stevanato Group Launches Vertiva, An Innovative On-Body Drug Delivery System for Enhanced Patient Care and Sustainability
13.3.2. Altaviz Introduces AltaVISC, A Revolutionary Auto-injector Platform Enhancing Drug Delivery Efficiency
13.3.3. Launch of UDENYCA Autoinjector Enhances Patient Accessibility and Administration Efficiency
13.4. Strategy Analysis & Recommendation
List of Figures
FIGURE 1. INJECTABLE DRUG DELIVERY MARKET RESEARCH PROCESS
FIGURE 2. INJECTABLE DRUG DELIVERY MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 5. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2030 (%)
FIGURE 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2023 VS 2030 (%)
FIGURE 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2030 (%)
FIGURE 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 14. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 15. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 16. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 17. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 18. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 19. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 22. INJECTABLE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 23. INJECTABLE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. INJECTABLE DRUG DELIVERY MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. INJECTABLE DRUG DELIVERY MARKET DYNAMICS
TABLE 7. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CONVENTIONAL INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOINJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY NEEDLE-FREE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY PEN INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY WEARABLE INJECTORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISPOSABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY REUSABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY CHRONIC DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOME CARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL INJECTABLE DRUG DELIVERY MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 28. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 29. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 30. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 31. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 32. AMERICAS INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 33. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 34. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 35. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 36. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 37. ARGENTINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 38. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 39. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 40. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 41. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 42. BRAZIL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 43. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 44. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 45. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 46. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 47. CANADA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 48. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 49. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 50. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 51. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 52. MEXICO INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 60. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 61. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 62. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 63. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 64. ASIA-PACIFIC INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 65. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 66. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 67. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 68. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 69. AUSTRALIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 70. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 71. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 72. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 73. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 74. CHINA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 75. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 76. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 77. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 78. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 79. INDIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 80. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 81. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 82. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 83. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 84. INDONESIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 85. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 86. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 87. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 88. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 89. JAPAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 91. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 92. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 93. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 94. MALAYSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 95. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 96. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 97. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 98. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 99. PHILIPPINES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 100. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 101. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 102. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 103. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 104. SINGAPORE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 105. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 106. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 107. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 108. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 109. SOUTH KOREA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 110. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 111. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 112. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 113. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 114. TAIWAN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 115. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 116. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 117. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 118. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 119. THAILAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 120. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 121. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 122. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 123. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 124. VIETNAM INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 125. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 126. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 127. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 128. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 129. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 130. EUROPE, MIDDLE EAST & AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 131. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 132. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 133. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 134. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 135. DENMARK INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 137. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 138. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 139. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 140. EGYPT INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 141. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 142. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 143. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 144. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 145. FINLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 146. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 147. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 148. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 149. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 150. FRANCE INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 151. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 152. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 153. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 154. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 155. GERMANY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 156. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 157. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 158. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 159. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 160. ISRAEL INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 161. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 162. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 163. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 164. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 165. ITALY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 166. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 167. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 168. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 169. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 170. NETHERLANDS INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 171. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 172. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 173. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 174. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 175. NIGERIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 176. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 177. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 178. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 179. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 180. NORWAY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 182. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 183. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 184. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 185. POLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 186. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 188. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 189. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 190. QATAR INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 191. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 192. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 193. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 194. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 195. RUSSIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 196. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 197. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 198. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 199. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 200. SAUDI ARABIA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 201. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 202. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 203. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 204. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 205. SOUTH AFRICA INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 206. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 207. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 208. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 209. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 210. SPAIN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 211. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 212. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 213. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 214. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 215. SWEDEN INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 216. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 217. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 218. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 219. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 220. SWITZERLAND INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 221. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 222. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 223. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 224. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 225. TURKEY INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 227. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 228. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 229. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 230. UNITED ARAB EMIRATES INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 231. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE TYPE, 2018-2030 (USD MILLION)
TABLE 232. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY SELF-INJECTION DEVICES, 2018-2030 (USD MILLION)
TABLE 233. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY USABILITY, 2018-2030 (USD MILLION)
TABLE 234. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2018-2030 (USD MILLION)
TABLE 235. UNITED KINGDOM INJECTABLE DRUG DELIVERY MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 236. INJECTABLE DRUG DELIVERY MARKET SHARE, BY KEY PLAYER, 2023
TABLE 237. INJECTABLE DRUG DELIVERY MARKET, FPNV POSITIONING MATRIX, 2023

Companies Mentioned

The leading players in the Injectable Drug Delivery market, which are profiled in this report, include:
  • AbbVie Inc.
  • Antares Pharma by Halozyme Therapeutics
  • Becton, Dickinson and Company
  • Eli Lilly and Company
  • Emperra GmbH
  • Enable Injections LLC
  • F. Hoffman - La Roche Ltd.
  • Insulet Corporation
  • Johnson & Johnson Services, Inc.
  • Medtronic PlC
  • Novo Nordisk A/S
  • Pfizer, Inc.
  • Ravimed Sp. z o.o.
  • Recipharm AB
  • Sanofi S.A.
  • SiO2 Medical Products
  • Stevanato Group
  • Tandem Diabetes Care
  • West Pharmaceutical Services, Inc.
  • Wilhelm Haselmeier GmbH & Co. KG

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages188
PublishedOctober 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 1.04 Trillion
Forecasted Market Value ( USD ) by 2030 $ 1.62 Trillion
Compound Annual Growth Rate7.5%
Regions CoveredGlobal
No. of Companies Mentioned20

Related Topics

Related Reports

Injectable Drug Delivery Devices Market Size, Share and Trends Analysis Report by Product (Devices, Formulations), Therapeutic Use (Autoimmune Disorders, Hormonal Disorders), End-use (Hospitals, Homecare Settings), and Region 2024-2030 - Product Image

Injectable Drug Delivery Devices Market Size, Share and Trends Analysis Report by Product (Devices, Formulations), Therapeutic Use (Autoimmune Disorders, Hormonal Disorders), End-use (Hospitals, Homecare Settings), and Region 2024-2030

  • Report
  • 100 Pages
  • Global
From
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel, Patient Care Setting, & Region - Forecast to 2029 - Product Image

Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious Diseases, Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel, Patient Care Setting, & Region - Forecast to 2029

  • Report
  • 387 Pages
  • Global
From
Injectable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030 - Product Image

Injectable Drug Delivery Devices - Market Insights, Competitive Landscape, and Market Forecast - 2030

  • Report
  • 150 Pages
  • Global
From
Injectable Drugs Market by Molecule Type, Drug Class, Injection Routes, Application - Global Forecast 2025-2030 - Product Image

Injectable Drugs Market by Molecule Type, Drug Class, Injection Routes, Application - Global Forecast 2025-2030

  • Report
  • 186 Pages
  • Global
From
Injectable Drug Delivery Devices Global Market Report 2024 - Product Image

Injectable Drug Delivery Devices Global Market Report 2024

  • Report
  • 250 Pages
  • Global
From
Copyright © 2002-2024 Research and Markets. All Rights Reserved.